|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,788.00 GBX | 0.00% |
|
+0.43% | +1.60% |
| 01-09 | Berenberg raises M&S; BofA cuts Barratt Redrow | AN |
| 12-09 | Deutsche Bank Research raises Relx to 'buy' | AN |
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.59 | 8.45 | 6.74 | 2.94 | 3.72 | |||||
Return on Total Capital | 10.23 | 11.75 | 9.55 | 4.12 | 5.19 | |||||
Return On Equity % | 12.44 | 7.29 | 10.69 | 3.77 | 4.49 | |||||
Return on Common Equity | 12.44 | 7.29 | 10.69 | 3.77 | 4.49 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.89 | 22.25 | 20.18 | 16.01 | 16.42 | |||||
SG&A Margin | 3.85 | 3.79 | 4.17 | 5.96 | 5.46 | |||||
EBITDA Margin % | 17.13 | 18.55 | 16.05 | 10.1 | 10.99 | |||||
EBITA Margin % | 17.03 | 18.47 | 15.97 | 10 | 10.91 | |||||
EBIT Margin % | 17.03 | 18.47 | 15.97 | 10 | 10.91 | |||||
Income From Continuing Operations Margin % | 12.51 | 6.86 | 10.71 | 5.48 | 5.66 | |||||
Net Income Margin % | 12.51 | 6.86 | 10.71 | 5.48 | 5.66 | |||||
Net Avail. For Common Margin % | 12.51 | 6.86 | 10.71 | 5.48 | 5.66 | |||||
Normalized Net Income Margin | 10.63 | 11.49 | 9.77 | 5.94 | 6.5 | |||||
Levered Free Cash Flow Margin | 10.11 | -3.29 | 6.91 | -1.93 | 6.47 | |||||
Unlevered Free Cash Flow Margin | 10.35 | -3.05 | 7.27 | -1.42 | 6.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.71 | 0.73 | 0.67 | 0.47 | 0.55 | |||||
Fixed Assets Turnover | 86.26 | 101.2 | 103.39 | 76.9 | 73.52 | |||||
Receivables Turnover (Average Receivables) | 126.67 | 109.67 | 82.99 | 77.28 | 104.42 | |||||
Inventory Turnover (Average Inventory) | 0.63 | 0.65 | 0.6 | 0.43 | 0.49 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.27 | 5.06 | 5.01 | 5.26 | 4.77 | |||||
Quick Ratio | 0.5 | 0.5 | 0.44 | 0.19 | 0.22 | |||||
Operating Cash Flow to Current Liabilities | 0.4 | 0.05 | 0.23 | -0.07 | 0.13 | |||||
Days Sales Outstanding (Average Receivables) | 2.88 | 3.33 | 4.4 | 4.74 | 3.5 | |||||
Days Outstanding Inventory (Average Inventory) | 583.3 | 561.2 | 603.96 | 850.45 | 749.53 | |||||
Average Days Payable Outstanding | 41.3 | 35.34 | 37.51 | 50.6 | 44.05 | |||||
Cash Conversion Cycle (Average Days) | 544.88 | 529.19 | 570.85 | 804.59 | 708.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.48 | 4.37 | 4.19 | 4.16 | 4.22 | |||||
Total Debt / Total Capital | 4.29 | 4.19 | 4.02 | 3.99 | 4.05 | |||||
LT Debt/Equity | 4.39 | 4.28 | 4.1 | 4.07 | 4.14 | |||||
Long-Term Debt / Total Capital | 4.2 | 4.11 | 3.93 | 3.91 | 3.97 | |||||
Total Liabilities / Total Assets | 29.7 | 32.44 | 32.31 | 30.69 | 31.54 | |||||
EBIT / Interest Expense | 45.46 | 47.69 | 27.48 | 12.4 | 13.49 | |||||
EBITDA / Interest Expense | 46.02 | 48.13 | 27.79 | 12.67 | 13.74 | |||||
(EBITDA - Capex) / Interest Expense | 45.74 | 48.09 | 27.65 | 12.59 | 13.21 | |||||
Total Debt / EBITDA | 0.27 | 0.22 | 0.26 | 0.59 | 0.49 | |||||
Net Debt / EBITDA | -0.58 | -0.35 | -0.39 | 0.1 | -0.07 | |||||
Total Debt / (EBITDA - Capex) | 0.28 | 0.22 | 0.26 | 0.6 | 0.51 | |||||
Net Debt / (EBITDA - Capex) | -0.59 | -0.35 | -0.4 | 0.1 | -0.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 40.31 | 13.27 | -3.68 | -30.13 | 16.91 | |||||
Gross Profit, 1 Yr. Growth % | 54.5 | 20.72 | -12.67 | -44.55 | 19.86 | |||||
EBITDA, 1 Yr. Growth % | 64.84 | 22.75 | -16.64 | -56.04 | 27.2 | |||||
EBITA, 1 Yr. Growth % | 65.34 | 22.92 | -16.7 | -56.25 | 27.51 | |||||
EBIT, 1 Yr. Growth % | 65.34 | 22.92 | -16.7 | -56.25 | 27.51 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 102.54 | -37.91 | 50.45 | -64.25 | 20.69 | |||||
Net Income, 1 Yr. Growth % | 102.54 | -37.91 | 50.45 | -64.25 | 20.69 | |||||
Normalized Net Income, 1 Yr. Growth % | 71.74 | 22.53 | -18.11 | -57.55 | 27.91 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 102.31 | -37.87 | 51.02 | -63.21 | 20.92 | |||||
Accounts Receivable, 1 Yr. Growth % | -47.37 | 179.41 | -27.16 | -21.97 | -2.59 | |||||
Inventory, 1 Yr. Growth % | 4.38 | 9.71 | 3.44 | 3.04 | 2.62 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.72 | -4.2 | -7.31 | -4.73 | 50.66 | |||||
Total Assets, 1 Yr. Growth % | 14.53 | 6.59 | 2.59 | -2.24 | 3.9 | |||||
Tangible Book Value, 1 Yr. Growth % | 9.81 | 2.43 | 2.79 | 0.11 | 2.62 | |||||
Common Equity, 1 Yr. Growth % | 9.81 | 2.43 | 2.79 | 0.11 | 2.62 | |||||
Cash From Operations, 1 Yr. Growth % | -846.98 | -89.6 | 424.89 | -127.73 | -312.52 | |||||
Capital Expenditures, 1 Yr. Growth % | -60.24 | -84.85 | 440 | -48.15 | 750 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -421.49 | -136.9 | -302.1 | -119.5 | -492.24 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -460.09 | -133.41 | -329.61 | -113.68 | -672.63 | |||||
Dividend Per Share, 1 Yr. Growth % | 135 | 19.15 | 0 | -61.43 | 29.63 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.42 | 26.07 | 4.45 | -17.96 | -9.62 | |||||
Gross Profit, 2 Yr. CAGR % | -9.14 | 36.53 | 2.68 | -30.41 | -18.48 | |||||
EBITDA, 2 Yr. CAGR % | -11.13 | 42.19 | 1.15 | -39.47 | -25.22 | |||||
EBITA, 2 Yr. CAGR % | -11.22 | 42.51 | 1.19 | -39.63 | -25.31 | |||||
EBIT, 2 Yr. CAGR % | -11.22 | 42.51 | 1.19 | -39.63 | -25.31 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -14.83 | 12.14 | -3.34 | -26.66 | -34.31 | |||||
Net Income, 2 Yr. CAGR % | -14.83 | 12.14 | -3.34 | -26.66 | -34.31 | |||||
Normalized Net Income, 2 Yr. CAGR % | -10.46 | 45.01 | 0.17 | -41.04 | -26.31 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -14.93 | 12.11 | -3.14 | -25.46 | -33.31 | |||||
Accounts Receivable, 2 Yr. CAGR % | -47.21 | 21.27 | 42.66 | -24.61 | -12.82 | |||||
Inventory, 2 Yr. CAGR % | 7.68 | 7.01 | 6.53 | 3.24 | 2.83 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.45 | -3.47 | -5.77 | -6.03 | 19.81 | |||||
Total Assets, 2 Yr. CAGR % | 9.65 | 10.49 | 4.57 | 0.15 | 0.78 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.09 | 6.06 | 2.61 | 1.44 | 1.36 | |||||
Common Equity, 2 Yr. CAGR % | 6.09 | 6.06 | 2.61 | 1.44 | 1.36 | |||||
Cash From Operations, 2 Yr. CAGR % | 21.72 | -11.84 | -26.1 | 20.65 | -23.23 | |||||
Capital Expenditures, 2 Yr. CAGR % | -19.56 | -75.46 | -9.55 | 67.33 | 109.94 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 40.66 | 8.88 | -13.64 | -37.23 | -12.55 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 38.28 | 9.65 | -12.41 | -43.96 | -11.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | -11.61 | 67.33 | 9.16 | -37.89 | -29.29 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.82 | 3.25 | 15.25 | -8.65 | -7.68 | |||||
Gross Profit, 3 Yr. CAGR % | -4.86 | -0.14 | 17.64 | -16.38 | -16.58 | |||||
EBITDA, 3 Yr. CAGR % | -6.51 | -1.05 | 19 | -23.38 | -22.47 | |||||
EBITA, 3 Yr. CAGR % | -6.6 | -1.08 | 19.15 | -23.48 | -22.54 | |||||
EBIT, 3 Yr. CAGR % | -6.6 | -1.08 | 19.15 | -23.48 | -22.54 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -9.08 | -23.34 | 23.69 | -30.62 | -13.41 | |||||
Net Income, 3 Yr. CAGR % | -9.08 | -23.34 | 23.69 | -30.62 | -13.41 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.07 | -0.62 | 19.86 | -24.76 | -23.67 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -9.18 | -23.39 | 23.82 | -29.85 | -12.42 | |||||
Accounts Receivable, 3 Yr. CAGR % | -24.47 | -8 | 2.32 | 16.67 | -17.89 | |||||
Inventory, 3 Yr. CAGR % | 7.22 | 8.35 | 5.81 | 5.35 | 3.03 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 39.7 | 4.7 | -4.76 | -5.42 | 9.98 | |||||
Total Assets, 3 Yr. CAGR % | 9.68 | 8.62 | 7.79 | 2.25 | 1.38 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.74 | 4.86 | 4.96 | 1.77 | 1.83 | |||||
Common Equity, 3 Yr. CAGR % | 8.74 | 4.86 | 4.96 | 1.77 | 1.83 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.41 | -46.38 | 59.78 | -46.7 | 45.71 | |||||
Capital Expenditures, 3 Yr. CAGR % | -5.59 | -53.89 | -31.23 | -24.86 | 187.65 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 25.11 | -9.98 | 33.81 | -47.41 | 15.62 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 23.84 | -13.9 | 40.28 | -52.83 | 21.61 | |||||
Dividend Per Share, 3 Yr. CAGR % | -6.34 | -2.36 | 40.95 | -22.83 | -20.63 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.86 | 6.69 | 2.87 | -5.83 | 4.57 | |||||
Gross Profit, 5 Yr. CAGR % | 2.56 | 3.53 | -1.93 | -13.57 | 1.59 | |||||
EBITDA, 5 Yr. CAGR % | 1.57 | 2.71 | -3.53 | -18.71 | -1.18 | |||||
EBITA, 5 Yr. CAGR % | 1.58 | 2.72 | -3.57 | -18.81 | -1.15 | |||||
EBIT, 5 Yr. CAGR % | 1.58 | 2.72 | -3.57 | -18.81 | -1.15 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -0.61 | -11.78 | -6.83 | -24.69 | -3.97 | |||||
Net Income, 5 Yr. CAGR % | -0.61 | -11.78 | -6.83 | -24.69 | -3.97 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.02 | 3.01 | -3.64 | -19.35 | -1.33 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -0.76 | -11.87 | -6.81 | -24.23 | -3.33 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.96 | 6.87 | -2.59 | -15.04 | -4.03 | |||||
Inventory, 5 Yr. CAGR % | 9.61 | 8.31 | 6.94 | 6.28 | 4.6 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.09 | 24.89 | 19.34 | 0.27 | 4.39 | |||||
Total Assets, 5 Yr. CAGR % | 11.44 | 9.63 | 7.61 | 5.15 | 4.93 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.98 | 8.97 | 6.24 | 3.48 | 3.5 | |||||
Common Equity, 5 Yr. CAGR % | 11.98 | 8.97 | 6.24 | 3.48 | 3.5 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.6 | -21.72 | -1.44 | -25.83 | 19.18 | |||||
Capital Expenditures, 5 Yr. CAGR % | -0.44 | -25.01 | -7.19 | -22.78 | 7.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 67.09 | 64.07 | 7.85 | -22.07 | 12.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 58.99 | 43.9 | 7.8 | -27.48 | 16.68 | |||||
Dividend Per Share, 5 Yr. CAGR % | 1.7 | 2.79 | -0.42 | -18.52 | 6.96 |
- Stock Market
- Equities
- BWY Stock
- Financials Bellway p.l.c.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















